StockNews.com downgraded shares of AxoGen (NASDAQ:AXGN – Free Report) from a buy rating to a hold rating in a research report sent to investors on Tuesday. A number of other research analysts have also weighed in on AXGN. Cantor Fitzgerald reissued an overweight rating and set a $12.00 price target on shares of AxoGen in […]
StockNews.com upgraded shares of AxoGen (NASDAQ:AXGN – Free Report) from a hold rating to a buy rating in a report issued on Friday morning. Several other equities analysts have also recently issued reports on the stock. SVB Leerink initiated coverage on shares of AxoGen in a research note on Monday, October 16th. They issued an […]
AxoGen (NASDAQ:AXGN – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a report issued on Friday. AXGN has been the topic of a number of other research reports. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $12.00 price objective on shares of AxoGen […]
AxoGen, Inc. (NASDAQ:AXGN – Get Free Report) was the recipient of a significant decrease in short interest in the month of January. As of January 15th, there was short interest totalling 1,410,000 shares, a decrease of 37.9% from the December 31st total of 2,270,000 shares. Based on an average trading volume of 532,500 shares, the […]
Cantor Fitzgerald restated their overweight rating on shares of AxoGen (NASDAQ:AXGN – Free Report) in a research note released on Friday, Benzinga reports. The brokerage currently has a $12.00 price target on the medical equipment provider’s stock. AXGN has been the subject of a number of other reports. SVB Leerink assumed coverage on shares of […]